Published in Allergy on December 01, 2006
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol (2013) 1.57
Specific immunotherapy in atopic dermatitis. Allergy Asthma Immunol Res (2014) 1.01
Neurogenic markers of the inflammatory process in atopic dermatitis: relation to the severity and pruritus. Postepy Dermatol Alergol (2013) 0.92
Chip-based immunoaffinity CE: application to the measurement of brain-derived neurotrophic factor in skin biopsies. Electrophoresis (2009) 0.86
A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects. Neuropeptides (2011) 0.81
Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients. Arch Dermatol Res (2012) 0.78
In utero Head Circumference is Associated with Childhood Allergy. Front Pediatr (2015) 0.77
Nasobronchial interaction. World J Clin Cases (2015) 0.76
Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo. Neuropsychiatr Dis Treat (2014) 0.75
Local Effect of Neurotrophin-3 in Neuronal Inflammation of Allergic Rhinitis: Preliminary Report. Balkan Med J (2015) 0.75
Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients. Braz J Med Biol Res (2015) 0.75
Brain-derived neurotrophic factor is increased in serum levels of patients with symptomatic dermographism. Postepy Dermatol Alergol (2017) 0.75
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10
Primary prevention of food allergy in children and adults: systematic review. Allergy (2014) 2.75
The diagnosis of food allergy: a systematic review and meta-analysis. Allergy (2013) 2.23
Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients. Br J Dermatol (2005) 2.09
EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy (2014) 2.05
Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology (2007) 2.02
The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy (2013) 2.02
Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology. Allergy (2004) 1.81
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy (2006) 1.80
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy (2014) 1.73
Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol (2002) 1.62
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55
A subset of CD8+ T cells from allergic patients produce IL-4 and stimulate IgE production in vitro. Clin Exp Allergy (1997) 1.51
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol (2012) 1.49
Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis--correlation with disease activity. Br J Dermatol (1996) 1.46
The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy (2004) 1.42
Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes. Clin Exp Immunol (1986) 1.40
[Atopic dermatitis. Version (17 July 2002 - modified final version)]. J Dtsch Dermatol Ges (2003) 1.39
[SAPHO syndrome. Case description of 3 patients with acne conglobata and osteoarticular symptoms]. Hautarzt (1997) 1.38
Severe adverse effects of protein A immunoadsorption. Lancet (1994) 1.37
Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm (2000) 1.37
Increased metal allergy in patients with failed metal-on-metal hip arthroplasty and peri-implant T-lymphocytic inflammation. Allergy (2009) 1.37
Desolvation process and surface characteristics of HSA-nanoparticles. Int J Pharm (2000) 1.33
Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther (2006) 1.32
EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy (2006) 1.28
Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol (1996) 1.24
Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma. Br J Ophthalmol (2001) 1.23
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol (2009) 1.19
Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas. Br J Cancer (2008) 1.17
Reproductive functions in young fathers and grandfathers. J Clin Endocrinol Metab (1982) 1.17
Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol (1999) 1.16
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy (2014) 1.16
Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy (2005) 1.14
Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol (1991) 1.10
Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake. J Microencapsul (2000) 1.10
55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression. J Invest Dermatol (1991) 1.10
Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm Res (1997) 1.10
Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol (2009) 1.09
Granulocyte-activating mediators (GRAM): I. Generation by lipopolysaccharide-stimulated mononuclear cells. J Invest Dermatol (1986) 1.09
Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy (2000) 1.09
C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J Immunol (1999) 1.07
C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol (1994) 1.06
Histamine H4 receptors modulate dendritic cell migration through skin--immunomodulatory role of histamine. Allergy (2008) 1.05
Phorbol-12-myristate-13-acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T-cell activation. J Invest Dermatol (1993) 1.05
Tumor necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression. J Invest Dermatol (1990) 1.05
C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins. Blood (1994) 1.05
Activated human T lymphocytes express a functional C3a receptor. J Immunol (2000) 1.04
Modulation of human neutrophilic granulocyte functions by recombinant human tumor necrosis factor and recombinant human lymphotoxin. Promotion of adherence, inhibition of chemotactic migration and superoxide anion release from adherent cells. Clin Exp Immunol (1988) 1.04
Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol (1996) 1.04
Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int J Pharm (2007) 1.03
High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol (1992) 1.02
Bacterial infections and atopic dermatitis. Allergy (2001) 1.02
Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med (1997) 1.02
EAACI/GA2LEN position paper: present status of the atopy patch test. Allergy (2006) 1.02
The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. J Clin Invest (1993) 1.01
Late eczematous reactions to food in children with atopic dermatitis. Clin Exp Allergy (2004) 1.01
Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy. Gut (1997) 1.01
Surface and mRNA expression of the CD52 antigen by human eosinophils but not by neutrophils. Blood (1996) 1.01
Steal syndrome after kidney transplantation caused by A-V fistula at the thigh. Child Nephrol Urol (1989) 1.01
Disseminated varicella in a patient with acute myelogenous leukemia: treatment with cytosine arabinoside. J Pediatr (1971) 1.00
Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol (1998) 0.99
Expression of interleukin (IL)-1 family members upon stimulation with IL-17 differs in keratinocytes derived from patients with psoriasis and healthy donors. Br J Dermatol (2011) 0.98
Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br J Dermatol (2001) 0.98
Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. J Allergy Clin Immunol (1997) 0.98
Induction of human granulocyte chemiluminescence by bacterial lipopolysaccharides. Infect Immun (1987) 0.97
Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol (1992) 0.97
Physical urticaria: classification and diagnostic guidelines. An EAACI position paper. Allergy (1997) 0.97
Retiform hemangioendothelioma: another tumor associated with human herpesvirus type 8? J Am Acad Dermatol (2000) 0.97
Dichotomy of blood- and skin-derived IL-4-producing allergen-specific T cells and restricted V beta repertoire in nickel-mediated contact dermatitis. J Immunol (1997) 0.97
Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions. Allergy (1997) 0.95
Anaphylatoxin C3a but not C3a(desArg) is a chemotaxin for the mouse macrophage cell line J774. Eur J Immunol (1998) 0.95
Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis. Clin Exp Allergy (2005) 0.95
Metabolism of glutamine in lymphocytes. Metabolism (1989) 0.95
Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma. Hum Genet (2000) 0.95
Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies. Immunology (1999) 0.95
The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells. Immunology (2000) 0.94